NCT06094608View on ClinicalTrials.gov

IBD-Sleep: A Pilot Study Looking at Changes in Sleep Timing and IBD Symptoms

NARecruitingINTERVENTIONAL
Enrollment

68

Participants

Timeline

Start Date

February 1, 2024

Primary Completion Date

May 31, 2026

Study Completion Date

May 31, 2026

Conditions
Inflammatory Bowel DiseasesUlcerative ColitisCrohn Disease
Interventions
DEVICE

Morning light treatment

Light therapy via the Re-Timer. Participants will conduct light treatment in the mornings at home for one hour using Re-timer®.

BEHAVIORAL

Treatment-as-usual

Participants will not make modifications to their activities or sleep schedule.

Trial Locations (1)

48105

RECRUITING

University of Michigan, Ann Arbor

All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

University of Michigan

OTHER